Research has shown that 5-HT inhibits insulin and glucagon secretion in healthy populations, while overexpression of 5-HT1D and 5-HT2A receptors in T2DM patients significantly increases glucose-stimulated insulin secretion [100], though the exact mechanisms require further investigation. The gene discussed is INS; the disease is type 2 diabetes mellitus.